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Abstract
Elevated concentrations of serum phosphate are linked with progression and
increased case fatality rate in animals and humans with chronic kidney disease. Ele-
vated concentrations of serum phosphate can be a risk factor for development of
renal and cardiovascular diseases or osteoporosis in previously healthy people. In
rodents, an excess intake of dietary phosphorus combined with an inverse dietary
calcium : phosphorus ratio (<1 : 1) contributes to renal calcification. Renal injury also
has occured in cats fed experimental diets supplemented with highly soluble phos-
phate salts, especially in diets with inverse calcium : phosphorus ratios. However, not
all phosphorus sources contribute similarly to this effect. This review, which focuses
on cats, summarizes the published evidence regarding phosphorus metabolism and
homeostasis, including the relative impact of different dietary phosphorus sources,
and their impact on the kidneys. No data currently shows that commercial cat foods
induce renal injury. However, some diets contain high amounts of phosphorus rela-
tive to recommendations and some have inverse Ca : P ratios and so could increase
the risk for development of kidney disease. While limiting the use of highly soluble
phosphates appears to be important, there are insufficient data to support a specific
upper limit for phosphate intake. This review also proposes areas where additional
research is needed in order to strengthen conclusions and recommendations regard-
ing dietary phosphorus for cats.
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1 | INTRODUCTION
Phosphorus (P) is a nutritionally essential macromineral and is
involved in most, if not all, of the metabolic reactions in the body,
including energy metabolism, bone and teeth formation, osmotic and
acid-base balance, electrolyte transport, and numerous enzyme
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systems; and is a constituent of nucleic acids.1-4 Most nonskeletal P in
the body is intracellular. The body controls extracellular P concentra-
tions primarily by regulation of urinary excretion but also by intestinal
absorption and deposition into and release from bound sources in
bone and other tissues.
Although P is essential, excess can be detrimental. Elevated con-
centrations of blood phosphate or maladaptive activation of hormonal
systems involved in regulating phosphate could have direct toxic
effects on the kidneys and cardiovascular system.5,6 Reducing serum
phosphate concentration (sPi) in subjects with chronic kidney disease
(CKD) delays progression and death.7-12 Evidence in humans suggests
that elevated sPi (in the high normal range or highest quartile in popu-
lation studies) can be a risk factor for development of renal disease,
cardiovascular disease, or osteoporosis, and is associated with increased
mortality.13-16 Although there are discrepancies between dietary P and
sPi, dietary factors do contribute to sPi, as detailed below. Human diets
considered to increase risk for elevated sPi are those high in added
phosphates (Pi) and low in calcium (Ca), resulting in inverse Ca : P ratios
(phosphorus greater than calcium) which is itself a risk factor for renal
injury.17,18 In cats, under some circumstances, intake of highly soluble Pi
salts can induce damage to otherwise healthy kidneys.19,20 The detri-
mental effects of the Pi salts are not limited to clearly excessive dietary
P nor inverse dietary Ca : P ratios. In some cases, the effects occur dur-
ing feeding of diets containing total P concentrations not in excess of
that found in some commercial diets, although the sources and propor-
tions of added Pi in the experimental diets differ from those in commer-
cial diets.
This review summarizes the published evidence regarding P metabo-
lism and homeostasis, including how these factors affect the kidneys. This
review further notes the limitations and gaps in the existing evidence, and
proposes areas where additional research is needed in order to strengthen
conclusions and recommendations regarding dietary P for cats.
2 | PHOSPHORUS DIGESTION,
METABOLISM, AND HOMEOSTASIS IN
MAMMALS
Dietary P is absorbed in the small intestine via 2 general mechanisms:
sodium-dependent active absorption (primary route), and concentration
dependent paracellular diffusion (secondary route) in humans and rodents.
Active absorption of P is up- or down-regulated depending on the animal's
needs and various regulating factors, while paracellular diffusion is more
dependent on the total amount consumed.21-23 Parathyroid hormone
(PTH), 1-25-dihydroxy vitamin D3 (1,25D3), fibroblast growth factor
23 (FGF23), thyroid hormone, glucocorticoids, estrogens and metabolic
acidosis are just some of the endogenous metabolic factors that can mod-
ify intestinal P uptake either directly or indirectly.2,23-25 In addition, P
absorption in most species is dependent on the intestinal pH, P needs of
the animal, source of P, and interactions with other dietary factors such as
dietary Ca, magnesium (Mg), and phytates.2,21,24-31 Metabolic acidosis
upregulates sodium-dependent P uptake in the intestines of mice while
simultaneously increasing urinary excretion of phosphate (Pi).2 Dietary Ca
and Ca : P ratio exert an influence over P availability, with intestinal
absorption of P inversely affected by dietary Ca and Ca : P ratio, thus
increasing when Ca : P is low. This has been demonstrated in dogs and
cats, as well as other animals.21,32 Likewise, dietary Mg affects intestinal
uptake of both Ca and P in both rats and cats, with higher Mg decreasing
uptake of Ca and P.26,31,33,34
Increased dietary protein appeared to enhance renal Pi excretion
and decrease Pi retention in both adult and growing cats, so P require-
ments might be dependent on dietary protein content.28,35,36 This
effect could be an artifact of protein's effect on pH. Since Pi is a criti-
cal component of urinary titratable acids used to remove excess acid
from the body in a buffered form (dihydrogen phosphate), an acidic
pH can increase urinary Pi (uPi) excretion. This has been confirmed in
cats in 1 study designed to evaluate dietary base excess on urine
pH.37 In that study, there was a significant, negative correlation
between urinary pH and uPi. Similarly, in cats given phosphoric acid
to increase urinary acidification, average 24-hour Pi excretion was sig-
nificantly higher than in cats with less acidic urine despite identical
dietary P concentrations.38 Thus, as urine becomes less acidic, uPi
decreases which could increase positive P balance and increase sPi.
Dietary P can be intrinsic to ingredients, such as meats, bone
meals, and grains, or be added as inorganic sources such as mined
phosphate rock, phosphoric acid, or various phosphate salts. (Table 1).
Phosphorus from animal sources is primarily present as calcium phos-
phates (such as hydroxyapatite) and phosphate esters. The apparent
digestibility of P ranges between 0% and 80% depending on source
and other dietary variables. Grain and oilseed based P is poorly
digested because it is primarily present as phytate, with digestibility
between 0% and 40%.16,22,39 Supplemental inorganic Pi, such as those
in phosphate-containing food additives, have an intestinal uptake of
80% or greater.16,39 One study comparing cats fed P coming primarily
from poultry, meat, fish meals with added inorganic Pi (mono- and di-
basic sodium phosphates) confirmed greater intestinal uptake of the P
from sodium phosphates, with about 40% absorption compared to
about 20% absorption for the diet containing primarily animal sources
of P.27 Concurrent with this were increases in sPi and uPi in cats fed
the more digestible sodium phosphate containing diet.27 Although
supplemental inorganic P sources are generally more bioavailable than
those intrinsic to food ingredients, they are not uniform is this respect. In
dogs, monosodium phosphate (NaH2PO4) and monopotassium phosphate
(KH2PO4) significantly increased sPi and PTH compared to similar amounts
of P from poultry meal (Herbst S, Dobenecker B. Effects of phosphorus
addition from organic and inorganic sources on kinetics of selected blood
parameters in dogs. Proc Eur Soc Vet Clin Nutr 2018, Munich, Germany.
Abstract) while another study showed that the effects of calcium diphos-
phate (Ca[H2PO4]2) were intermediate between phosphorus from poultry
meal and monosodium phosphate (Siedler S, Dobenecker B. Effect of dif-
ferent P sources in high phosphorus diets with balanced Ca/P ratio on
serum PTH, phosphorus and calcium levels as well as apparent digestibility
of these minerals in dogs. Proc Eur Soc Vet Clin Nutr 2015, Toulouse,
France. Abstract).
Meta-analysis of digestion trials in dogs and cats estimated the
average true digestibility of P to be 17% in dogs and 31% in cats.32 In
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both dogs and cats, as in other species, Ca : P ratio affects P diges-
tion : higher ratios are associated with lower digestibility. Adult cats
fed diets with Ca : P ratios of 1 : 1 have apparent digestibility of P
averages about 50%, while increasing Ca to a ratio of 2 : 1 or 4 : 1
reduces apparent absorption.40 The reverse also holds true, with P
digestibility increased when the Ca : P ratio is less than 1 : 1.30,32 The
average true digestibility of dietary P was summarized as: 49% when
the Ca : P was less than 1 : 1; 27% when the Ca : P ratio fell between
1 : 1 and 2 : 1; and approximately 0% when Ca : P was greater than
2 : 1.32 It is not known how much of this effect is strictly the Ca : P
ratio or if differences in P sources or other dietary variables affect the
apparent digestibility of P.
Dietary Mg is another macromineral that interacts with Ca and
P. In cats, as dietary Mg (added as MgCO3) increases, intestinal
absorption of dietary P and urinary excretion of Pi are both reduced in
a linear manner.31 In addition to impact on Pi homeostasis, low serum
Mg is correlated with CKD, cardiovascular disease and all-cause mor-
tality.6,41,42 Mg can reduce vascular mineralization in the face of
hyperphosphatemia, reduce sPi, and reduce FGF23 which indepen-
dently contribute to death in CKD.6,41-43
In healthy subjects, nearly 100% of sPi is filtered via the renal glo-
merulus and 80% to 90% is typically reabsorbed via sodium-mediated
facilitated cotransporters in the renal tubules.16 That portion not
reabsorbed is excreted in the urine. Total renal phosphorus excretion
is balanced to phosphorus intake under the control of PTH, 1,25D3,
and FGF23 (and its cofactor !-klotho) so as to maintain sPi within a
fairly stable range.4,44 In cats, for example, acute responses to high
intake of readily available inorganic phosphate appear to involve rapid
secretion of PTH, resulting in increased uPi.45 Adaptation to longer
term feeding of cats with diets high in readily available phosphate
results in increases in both FGF23 and PTH, both increasing uPi.19 In
a healthy adult animal at steady state (not pregnant or lactating), the
total urinary Pi is thought to approximate the amount absorbed in the
intestines,46,47 although exceptions to this have been noted.47,48 In
particular, with inadequate intake of P or low absorption of P from
the intestine, uPi is low and may serve as an indicator of altered P reg-
ulation.44,49 In the face of kidney disease, however, urinary excretion
of P is compromised.50
The amount of phosphorus entering renal tubules is dependent
on glomerular filtration, as there are no other mechanisms by which
additional Pi can be added to the filtrate. Thus, for a given sPi, the
amount of Pi entering the tubules is dependent on glomerular filtra-
tion rate (GFR). As GFR decreases in the face of CKD, the amount of
filtrate decreases. Likewise, for a given GFR, the sPi affects the
amount of Pi entering the tubules. Thus, as sPi increases, the amount
of Pi entering the tubules increases despite the reduced GFR. Once in
the renal tubules, reabsorption or excretion is controlled by PTH,
1,25D3, and FGF23, as noted above. However, these also are impacted by
CKD. Both FGF23 and PTH are increased in CKD which result in reduced
renal tubular reabsorption of Pi and greater urinary Pi excretion, reduced
activation of 1,25D3 and reduced intestinal P absorption,51maintaining sta-
ble sPi despite reduced GFR. As CKD progresses, however, there is a
reduction in kidney-derived !-klotho, an essential cofactor for FGF23.25,52
In the absence of !-klotho, FGF23 is nonfunctional, thereby limiting the
kidney's ability to regulate Pi reabsorption despite increased concentrations
of FGF23. As the ability to regulate Pi homeostasis continues to decline
with advancing CKD, sPi increases until a new equilibrium is reached but at
a greater sPi. The increase in PTH, FGF23 and sPi that occur in CKD all are
associated with ongoing renal damage and increased mortality rates.53-55
3 | PHOSPHORUS DYSREGULATION AND
IMPACT ON RENAL HEALTH
Hyperphosphatemia contributes to ongoing damage in the face of
existing kidney disease, and dietary P restriction can help reduce this
ongoing damage.8,16,56-58 In humans, hyperphosphatemia secondary
to CKD is linked with disease progression, increased vascular damage
and cardiovascular morbidity and death.16,23,58 In mice with CKD fed
high P diets (ie, 0.9% P vs 0.5% P; Ca : P 0.66 : 1 vs 1.2 : 1), high P
intake results in vascular calcification which can aggravate CKD or
contribute to cardiovascular disease.59,60 Elevations in serum PTH and
FGF23, which are stimulated in healthy subjects by increased P intake
and which are increased in patients with established CKD, are associ-
ated with increased risk of CKD progression6,61 Likewise, in cats, ele-
vations in sPi, PTH and FGF23 are risk or prognostic factors for all-
cause mortality and progression of CKD.55,62-65 Serum Pi is positively
correlated with severity of interstitial fibrosis in cats with CKD.66
However, it is not known if these substances actually contribute to
renal injury, or are simply markers of ongoing renal injury.16
Female rats are predisposed to development of nephrocalcinosis,
or calcification of kidney tissue especially at the corticomedullary
junctions. This form of kidney disease is responsive to dietary P and
to the dietary Ca : P ratio.18,67-70 An inverse Ca : P ratio (Ca less than
P) appears to be the primary risk factor although absolute amounts of
Ca and P also influence nephrocalcinosis.18,68 For example, when
female rats were fed a diet that contained approximately 5 g Ca and
6 g P/kg dry diet and had a molar Ca : P ratio of about 0.66 : 1, kidney
tissue accumulated 171 ± 130 "mol calcium/g dry tissue weight. In
the same study, female rats fed diets modified with considerably more
Ca and P but molar Ca : P ratios of 1.1-1.2 : 1 showed significantly less
calcification. The highest Ca diet, containing 20 g Ca and 13 g P/kg
dry diet, with a molar Ca : P ratio of 1.2 : 1, resulted in only
39 ± 31 "mol calcium/g dry tissue weight despite containing 4! more
Ca and 2! more P than the diet with the inverse Ca : P ratio.68
In dogs with induced CKD, restriction of dietary P reduces the
associated morbidity and improves survival.56,71,72 In cats with induced
renal failure, restriction of dietary P from 1.56% of diet dry matter
(DM) to 0.42% results in less renal mineralization, fibrosis and inflam-
matory cell infiltration.7 Cats on the lower P intake also have lower
serum Pi and PTH concentrations compared to those fed the high P
diet. It is important to note that the high P diet used a highly soluble
inorganic P salt mixture (Na3PO4) for a large portion of the P (about
73% of total P, or 1.1% diet DM added Pi) and also had an inverse Ca : P
ratio, both of which can alter bioavailability and renal effects of P.7
While no studies have evaluated P restriction alone in cats with
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naturally occurring CKD, several do show clinical benefits in cats with
CKD fed “renal diets” (restricted in phosphorus, protein, and sodium,
plus alkalinizing buffers and often with other changes compared to
maintenance diets) or those treated with phosphate binders.9,10,73,74
Evidence in people has been accumulating that elevations in sPi
can be a risk factor for development of renal disease, cardiovascular
disease and increased mortality even in patients with apparently nor-
mal kidney function.14-17 These epidemiological studies evaluated sPi
rather than intake, and the association between dietary P and sPi is
weak at best.58,75,76 Discrepancies between dietary P and sPi in
healthy subjects are due to several factors including normal diurnal
variation in sPi and efficient excretion of excess P such that fasting
sPi does not change with alterations in P intake.15,77,78Serum Pi,
which represents only about 1% of total body P, also can be affected
by fluxes into and out of intestine, bone and intracellular spaces.76,78
Additional factors include differences in bioavailability of various P
sources, and other dietary factors that can alter P absorption, such as
the dietary Ca : P ratio.15,45,58 Studies evaluating P intake yielded
mixed results regarding impact on morbidity or mortality rates. For
example, the NHANES III study found no association between dietary
P and mortality in patients with compromised renal function, yet
another study in dialysis patients reports a strong association between
dietary P and mortality rate.16 In the NHANES III study, analysis of
data from the subset of subjects that were healthy at the start of the
study demonstrated a positive association between diet P and mortal-
ity among individuals consuming more than 1400 mg per day.79 How-
ever, in that same study, diets with the lowest P concentrations
(energy basis) were also associated with greater all-cause mortality.79
A study in human patients with or without diabetes mellitus docu-
mented an increased risk for development of CKD in those diabetic
patients consuming the highest P diets, but no impact was observed
in the nondiabetic subjects.80
A small study in pet dogs and cats suggests a positive correlation
between high P intake (assessed through dietary questionnaire) and
CKD in cats, but not in dogs.81 Median P intake at the time of diagno-
sis was 239% of the recommended allowance in cats with CKD and
147% of the recommended allowance in the controls. Home-made
diets were the most commonly fed diet type in this study, and the P
sources and Ca : P ratio were not reported. In a different study of
aged cats (10 years of age or older) without clinical evidence of CKD,
a higher P diet (2.6 g/Mcal) had no impact on development of azote-
mic CKD compared with those fed a lower P diet (1.6 g/Mcal) over an
18-month period.77 It should be noted that in this study the overall
prevalence of azotemic-CKD was less than expected, so the study
might have been underpowered to detect an effect from P intake.
High Pi concentrations alter vascular and endothelial function and
alter the nitric oxide pathway in in vitro studies.82,83 It is hypothesized
that these changes can contribute to increased proteinuria, which
might contribute to further renal injury.16 In human patients with and
without CKD, there is a significant association between sPi or uPi
excretion and proteinuria.16 The endothelial effects have been con-
firmed with in vivo studies in humans and rats.82-85 For example,
healthy men fed 1200 mg P (vs 400 mg P) show 2-hours postprandial
elevations in sPi and compromised vascular function measured as
flow-mediated dilation of the brachial artery. However, the Ca : P
ratio in this treatment group was 0.167 : 1.82 The lower the dietary
Ca : P ratio, the higher the apparent likelihood of adverse effects
related to any given dietary P intake.58 Lack of control of the Ca : P
ratio is a common confounding issue in studies investigating the
effects of high P intake.15,16,70,79,82-84
4 | EVIDENCE FOR PHOSPHORUS' ROLE
IN RENAL HEALTH IN CATS
Although there is currently no evidence that P in commercial cat
foods induces renal disease in healthy cats, high “ash” content in food
might be a risk factor for developing CKD.86 Ash refers to all the min-
erals in food, and this includes P but is not specifically correlated to
it. In that study, higher intakes of dietary fiber, magnesium and sodium
all were associated with reduced risk for CKD. Each of these nutrients
can impact dietary P availability. Another small study suggests that
increased P and protein intakes might be associated with CKD in cats.81
Studies in healthy cats show an impact of dietary P, or inverse
Ca : P ratios, on markers of kidney function.19,20,87,88 In the earliest
study, cats were fed 4 purified diets each for 28 days with incremental
increases in dietary P (4.6, 9.2, 18.4, and 27.7 mmol/MJ [0.28%,
0.56%, 1.12%, and 1.71% of dry diet]). Dietary Ca was held constant
so that the Ca : P ratio decreased with increasing dietary P, provided
as sodium dihydrogen phosphate dihydrate (NaH2PO4-2H2O). The
Ca : P ratios ranged from 1.8 : 1 down to 0.3 : 1.87 At the highest P
level tested (with lowest Ca : P ratio), food intake decreased; sPi was
reduced and serum alkaline phosphatase increased. Also, in this diet
group, creatinine clearance decreased, suggesting an adverse impact on
renal function in otherwise healthy cats. Fasting sPi was reduced with
the higher dietary P and reduced GFR, although the significance of this
is not known.
In the second study, healthy cats developed glucosuria, micro-
albuminuria and showed significantly decreased creatinine clearance
within 28 days of being fed a diet containing approximately 3 g
P/Mcal ME (1.6% of diet DM) with approximately 2/3 provided as a
combination of monocalcium (CaH4[PO4]2) and monosodium-(NaH2PO4)
phosphates.20 The amount of phosphorus from highly soluble mono-
sodium phosphate was approximately 0.4 g/Mcal ME or 0.17% of diet
DM, in a diet with a Ca : P ratio of approximately 0.4 : 1.
A third study compared a diet supplemented with sodium dihydrogen
phosphate (SDHP: NaH2PO4, also referred to as monosodium phosphate)
to deliver 4.78 g P/Mcal ME (1.93% diet DM) with a Ca : P ratio of 0.6 to
a control diet providing 1.23 g P/Mcal ME (0.52% diet DM) and Ca : P at
1.1.19 Within 4 weeks after starting on this HP-NaP diet, cats developed
changes consistent with renal injury: increased plasma creatinine and urea
nitrogen; increased urinary microalbuminuria; decreased GFR; and ultra-
sound echogenicity changes consistent with altered renal morphology.
GFR also decreased in the control group, but to a lesser extent than the
HP-NaP group. A final study evaluated a more moderate diet providing
3.6 g P/Mcal ME (1.5% diet DM), including approximately 1.5 g P (0.6%
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diet DM) from SDHP, and a Ca : P ratio of 0.9.19 Urinary albumin excre-
tion was significantly increased in the higher P cats by week 4 and
remained elevated throughout the study. Three cats (12.5%) fed this diet
developed biochemical evidence of kidney disease and 36% of the cats
showed evidence of altered renal morphology. In addition, 15 cats (60%)
fed this diet developed renal stones, compared with 6 cats (27%) fed the
control diet.19 Thus, multiple studies show adverse renal effects in cats
fed diets containing highly soluble inorganic Pi especially, but not exclu-
sively, in diets with a Ca : P ratio less than 1 : 1—findings consistent with
those reported in other species. A key question not addressed in these
studies is the applicability of these findings to other P sources.
The studies above did not compare the effects of different P sources
on renal biomarkers, however other research evaluated different P sources
on other physiologically important parameters. One study compared a mix
of dietary P sources (poultry, meat, fish meals, and calcium phosphate) with
supplemental inorganic P from mono- and di-basic sodium phosphates, and
confirmed significantly greater uptake, along with increases in sPi and uPi
in cats fed the more digestible inorganic P.27 Two studies in cats compared
diets providing P only from rice and beef (total P approximately 0.54%-
0.64% DM) with high P diets providing additional P from either mono-
sodium phosphate (HP-NaP: total P, 1.7% DM) or monocalcium phosphate
(HP-CaP: total P, 1.5% DM).88 Monosodium phosphate is a water soluble P
source whereas monocalcium phosphate is poorly water soluble.89 The
Ca : P ratio was held constant for all diets at about 1.3 : 1. Each diet was
fed for 29 days. Urine volume doubled in cats fed HP-NaP diet (which was
high in sodium as well as P). Despite this increase in volume, uPi concentra-
tion increased. Glucosuria occurred in 54% of cats fed this diet but did not
occur with the HP-CaP diet. The authors concluded the differences in
phosphaturic effects were due to the high solubility of monosodium
phosphate.88
A different study design was used in series of acute kinetic trials in
cats fed diets with 2 different inorganic sodium phosphate sources, SDHP
and sodium tripolyphosphate (Na5P3O10).
45 Each randomized, cross-over
trial measured relevant blood parameters (plasma Pi, PTH and FGF-23
concentrations, and whole blood ionized Ca) over a 6-hour postprandial
period with no dietary adaptation period. The trials indicate a dose-
dependent and threshold effect from the supplemental sodium phos-
phates on plasma Pi: at 0.5 g P/Mcal (0.64 g kg diet DM) or greater added
inorganic Pi, plasma Pi and PTH increases and blood iCa decreases,
whereas with lesser additions or with increased food-source P, no
increases in plasma Pi or PTH occurs during the 6-hour postprandial
period. Furthermore, the Ca : P ratio of the diet affects the response to
dietary sodium phosphates, with a prolonged elevation in plasma Pi in
cats fed diets with Ca : P less than 1 : 1.45 Given that prolonged eleva-
tions in blood Pi are associated with renal injury and increased all-cause
mortality, at least in humans, this can have clinical importance.14
5 | PHOSPHORUS IN COMMERCIAL CAT
FOODS
Phosphorus sources have many uses in pet food in addition to their
contribution to nutritional adequacy. Some of these functional uses
include: control of urine pH for prevention of stone formation (ie,
phosphoric acid); reduced accumulation of dental tartar (ie, sodium
hexametaphosphate); and, processing aids to ensure optimal cooking
and texture (ie, sodium phosphates). Among commercial cat foods in
the United States, the most commonly added phosphorus sources for
wet foods include tricalcium phosphate, dicalcium phosphate, and
sodium tripolyphosphate, while phosphoric acid and dicalcium phos-
phate are the most commonly added sources of phosphate in dry cat
foods (Table 1).
United States pet food regulations address both nutrient content
of foods and ingredients used. Table 2 lists the recommendations for
Ca and P levels as cited by the NRC (National Research Council),
AAFCO (Association of American Feed Control Officials), and FEDIAF
(Fédération européenne de l'industrie des aliments pour animaux
familiers—The European Pet Food Industry Federation).90-92 None of
these organizations currently list a maximum or safe upper limit for
phosphorus for cat foods although FEDIAF does list a maximum for
the Ca : P ratio of 2 : 1, and both FEDIAF and AAFCO provide maxi-
mum limits for phosphorus for dog foods. In 2019, FEDIAF added a
TABLE 2 Calcium and phosphorus
recommendations for cats
Calcium (minimum) Phosphorus (minimum)
g/Mcal g/100 g DM g/Mcal g/100 g DM Ca : P ratio
FEDIAF
Growth and reproduction 2.5 1.0 2.1 0.84 1 : 1 to 1.5 : 1
Adults, 100 kcal/kg0.67 1.48 0.59 1.25 0.50 1 : 1 to 2 : 1
Adults, 75 kcal/kg0.67 1.97 0.79 1.67 0.67 1 : 1 to 2 : 1
AAFCO
Growth and reproduction 2.5 1.0 2.0 0.8 NRb
Adults 1.5 0.6 1.25 0.5 NRb
NRC (RA)a
Growth and reproduction 2.7 1.9 NRb
Adults 0.72 0.64 NRb
aRA, recommended allowance.
bNR, no recommendation.
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footnote relative to P, stating “High intake of inorganic phosphorus
compounds (such as NaH2PO4) may affect indicators of renal health
in cats (Alexander et al 2018, Dobenecker et al 2018 a, b). More
research is needed to clarify potential risk.”92
United States pet food regulations require all ingredients, includ-
ing specific sources of P, to be listed individually in descending order
by weight but this is not required for European pet foods. Further-
more, neither US nor European regulations require that total amounts
of P or Ca be listed on commercial pet food labels. Many cat foods in
the United Kingdom are not in compliance with published nutritional
guidelines, and more relevant to the topic of this paper, about 10%
have inverse Ca : P ratios (below 1 : 1).93 Likewise, among 82 cat
foods sold in the United States, approximately 16% had an inverse
Ca : P ratio.94 Given that the combination of low Ca : P ratios coupled
with use of some highly soluble Pi salts are associated with markers of
renal injury, it is important to address this potential danger. Although
much remains to be studied, currently available data suggests the need
to maintain dietary Ca : P at or above 1 : 1, while also avoiding excess
inorganic Pi salts. However, specific guidelines regarding inorganic Pi
salts require additional data as different inorganic Pi show differences
in bioavailability and may differently impact renal health.27,45,88
6 | WHAT CONCLUSIONS CAN AND
CANNOT BE DRAWN BASED ON CURRENTLY
AVAILABLE EVIDENCE?
Based on currently available evidence, it is clear that excess phospho-
rus, especially when provided as highly soluble inorganic phosphate
salts, can be damaging to kidneys. This effect appears to be more pro-
nounced in foods with an inverse Ca : P ratio. What is not known is
the impact of various phosphate salts which vary in digestibility and
physiological effects. Safe upper limits have not been established for
the various Pi salts. Adverse effects can occur with high Pi diets in rel-
atively short term studies, but might lower amounts be detrimental
over longer periods or do physiological adaptations occur to protect
against these effects and, if so, do individuals vary in their ability to
adapt? Other dietary factors, such as the presence of phytates, fibers,
other minerals, differences in base excess and differences in the base
diet matrix, also may alter the impact of dietary P. No data currently
shows that commercial diets induce renal injury. However, some com-
mercial diets contain high amounts of phosphorus relative to recom-
mendations and some have inverse Ca : P ratios, so could increase the
risk for development of CKD.
It is clear that more research is needed. Until more evidence is
available, the authors recommend avoiding diets with a Ca : P less
than 1 : 1. Postprandial increases in serum Pi and PTH can occur when
highly soluble sodium phosphates are added to diets in amounts equal
to or greater than 0.5gP/Mcal, despite a Ca : P ratio above 1 : 1. How-
ever, similar results do not occur with other inorganic phosphates,
such as calcium phosphates, and many inorganic phosphate sources
have not yet been evaluated in this manner. While limiting the use of
highly soluble phosphates, such as sodium- or potassium-phosphates,
appears to be important, there are insufficient data to support a spe-
cific upper limit for inorganic or soluble phosphates at this time.
Among the additional research needed are studies to identify sensitive
markers of renal injury; to identify risk, if any, from current commer-
cial products; and to generate more information about the kinetics,
impact of different phosphorus sources, and the physiological adapta-
tions to long term feeding of highly bioavailable phosphates.
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